Changes to the ways in which the FDA plans to regulate vaccines represent a threat to effective vaccines and public health, ...
In October 2025, the FDA released a revised guidance titled, “Expanded Access to Investigational Drugs for Treatment Use—Questions and Answers.” ...
The FDA encourages sponsors to discuss plans to use animal testing alternatives, called new approach methodologies or NAMs, ...
In the wake of the memo, several vaccine experts responded that the CBER director's claim about the deaths requires more ...
Drastic overhauls of U.S. vaccine regulations proposed by top FDA official Vinay Prasad, M.D., have drawn harsh pushback from ...
In its latest PFDD installment, the FDA offers a detailed roadmap for sponsors seeking to design, adapt, or validate COAs that accurately ...
The U.S. Food and Drug Administration (FDA) has been rocked by recent changes to several leadership roles while it has ...
Twelve former U.S. FDA commissioners said on Wednesday they were deeply concerned about proposed changes to vaccine ...
For certain monospecific antibodies, three-month toxicology studies plus other supportive evidence will suffice, eliminating ...
A dozen former leaders of the U.S. Food and Drug Administration (FDA) slammed the Trump administration Wednesday over its ...
On , The US Food and Drug Administration issued draft guidance identifying specific types of monoclonal antibody products for which the agency believes six-month toxicity testing in non-human primates ...
Scholars argue that federal drug agency actions should take precedence over conflicting state regulations. How should courts handle state regulations that restrict access to pharmaceuticals previously ...